Email This Article

Headlines & Perspectives
FDA Seeks More Data on Blood Cancer Drug
By Adam Feuerstein
07/06/09 - 10:04 AM EDT
The FDA has completed its review of Spectrum Pharma's drug Zevalin, but final approval of the drug will probably be delayed two months.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,328.89 1,102.47 2,211.69 35.46
Oil *
73.88
UP
20.63
UP
6.40
UP
31.64
UP
0.59
10 Yr
3.55%
SPDR Gold
108.95
+0.20%
+0.58%
+1.45%
+1.69%
Data delayed 20 minutes

More From TheStreet

Latest Headlines

Brokerage Partners